GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DuoGenic StemCells Corp (ROCO:7607) » Definitions » Land And Improvements

DuoGenic StemCells (ROCO:7607) Land And Improvements : NT$0.00 Mil (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is DuoGenic StemCells Land And Improvements?

DuoGenic StemCells's land and improvements for the quarter that ended in Dec. 2024 was NT$0.00 Mil.


DuoGenic StemCells Land And Improvements Historical Data

The historical data trend for DuoGenic StemCells's Land And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DuoGenic StemCells Land And Improvements Chart

DuoGenic StemCells Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Land And Improvements
- - - -

DuoGenic StemCells Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Land And Improvements Get a 7-Day Free Trial - - - - -

DuoGenic StemCells Land And Improvements Calculation

Land is the surface or crust of the earth, which can be used to support structures, and may be used to grow crops, grass, shrubs, and trees. Land is characterized as having an unlimited life (indefinite). Land improvement is a long-term asset which indicates the cost of the constructed improvements to land, such as driveways, walkways, lighting, and parking lots.


DuoGenic StemCells Business Description

Traded in Other Exchanges
N/A
Address
Room R207, Innovation Incubation Center, 145, Xingda Road, South District, Taichung, TWN
DuoGenic StemCells Corp is a company having a team of passionate researchers focused on stem cell cultivation. Their products are intended for research use and can be upgraded for clinical applications. It also develops blood cell therapy programs, using the isolation and purification of blood mononuclear cells to remove granule cells that promote inflammation, and conducts clinical trials on various degenerative diseases to provide a convenient and simple new option for cell therapy.

DuoGenic StemCells Headlines

No Headlines